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FIGURE 1 Flare Spots Observed in IVOCT Images of Absorb Stent
(A,B) Stent deployed in a patient coronary artery (arrows); (C,D) phantom vessel with successive intravascular optical coherence tomography
(IVOCT) images at 100-mm intervals; and (E,F) corresponding micro-CT images at 50-mm intervals. Adjacent struts (green and yellow ovals)
merge at the luminal side of the stents and form a gap at the vessel wall. (G) Reﬂections at gap boundaries result in ﬂare spots.
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1175on the arterial side of the stent. The appearance of
ﬂare spots in IVOCT images is consistent with light
reﬂecting from surfaces formed at these gap bound-
aries before returning to the catheter.Sahar Elahi, PhD
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2012;76:342–50.Cardiac Steatosis and Left Ventricular
Dysfunction in HIV-Infected Patients Treated
With Highly Active Antiretroviral TherapyHeart disease is a major contributor to morbidity and
mortality in persons infected with human immuno-
deﬁciency virus (HIV), and both HIV and highly active
antiretroviral therapy (HAART) may be associated
with abnormalities in cardiac function and meta-
bolism (1). Ectopic fat deposition in cardiomyocytes
constitutes one possible mechanism, especially
considering the inﬂuence of HIV itself and HAART
on the human metabolic milieu. To test this
hypothesis, we studied 27 HIV-seropositive (þ) cases
on stable HAART ($3 years) and 22 HIV-negative
control subjects; neither group had history of
personal or family history of cardiovascular disease.
Myocardial triglyceride content was measured by
magnetic resonance spectroscopy (3T MAGNETOM
Verio, Siemens, Germany) (2) and revealed a 3-fold
elevation in cases compared with control subjects
(Figure 1A). To assess left ventricular (LV) function,
magnetic resonance tissue tagging was performed
on a mid-ventricular short-axis image (3). Both peak
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1176circumferential strain and the peak rate of
circumferential strain in diastole were impaired in
cases compared with control subjects (Figures 1B
and 1C, respectively). Clinical evidence of lipo-
dystrophy was also assessed by physical exam of
the dorsal back, neck, extremities, and abdomen.
Myocardial triglyceride content was signiﬁcantly
associated with circumferential strain (r ¼ 0.41,
p ¼ 0.009) and diastolic strain rate (r ¼ –0.47,
p ¼ 0.004). Moreover, HAART exposure was also
signiﬁcantly associated with myocardial triglycerideFIGURE 1 Ectopic Fat Deposition and LV Dysfunction in HIV-Infected
(A) Representative illustration of a typical cardiac magnetic resonance (C
the intraventricular septum illustrates the voxel position during spectro
showing a large area of resonance for myocardial water and a small area
above for a representative human immunodeﬁciency virus (HIV)-positive
(green line). The summary data demonstrate a 3-fold elevation in myoc
well-matched HIV-negative control subjects (green bar). (B, i to iv) Repr
tagging applied at end diastole (i) and progressing to end systole (iv). T
HIV-positive subject (pink line) and control subject (green line). The sum
control subjects. (C, i to iv) Representative illustration of a mid-short-axis
(i), progressing to diastasis (iv). The graph represents the diastolic circu
(pink line) and a control subject (green line). Time 0 represents end sys
summary data show impaired diastolic strain rate in cases versus contro
antiretroviral therapy; 1H MRS ¼ hydrogen ion magnetic resonance speccontent (r ¼ 0.42, p ¼ 0.043) and diastolic strain rate
(r ¼ –0.43, p ¼ 0.029), both of which were signiﬁ-
cantly higher with clinical presence of lipodystrophy
(p ¼ 0.02 and 0.001, respectively).
The data herein support the hypothesis that
ectopic fat deposition in the myocardium may
contribute to cardiac disease in patients with HIV
infection treated with HAART. In this study, clinically
visible lipodystrophy predicted myocardial triglycer-
ide content and LV dysfunction in HIV(þ) patients;
this may provide an important mechanistic insightPatients Receiving HAART
MR) image, showing all 4 chambers of the heart. The white box over
scopy. The green line illustrates a representative cardiac spectra,
of resonance for myocardial triglyceride content; magniﬁed directly
(þ) subject (pink line) and a representative HIV-negative (–) subject
ardial triglyceride content in HIV-positive subjects (pink bar) versus
esentative illustration of a mid-short-axis image of the LV, with tissue
he graph shows the circumferential strain from a representative
mary data demonstrate impaired circumferential strain in cases versus
image of the left ventricle, with tissue tagging applied at end systole
mferential strain rate from a representative HIV-positive subject
tole. The dashed line indicates the rate of ventricular relaxation. The
l subjects. Data are presented as mean  SE. HAART ¼ highly active
troscopy.
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1177into the pathogenesis of heart disease in patients
treated for HIV infection. Lipodystrophy can indeed
lead to ectopic spillover of triglyceride into non-
adipose tissues—including the myocardium—and has
previously been associated with adverse LV remod-
eling (2). Furthermore, that HAART exposure also
predicted myocardial triglyceride content and LV
dysfunction provides further insight into the
pathogenesis of heart disease in HIV(þ) patients.
For example, HAART has been associated with
lipodystrophy, hyperlipidemia, and hyperglycemia
(4) and may be directly cardiotoxic (5). Thus,
whereas HAART has signiﬁcantly reduced HIV-
related morbidity and mortality, we speculate that
HAART may also contribute to the cardiovascular
decline in HIV(þ) patients. Future studies are
warranted to further investigate these ﬁndings.Michael D. Nelson, PhD
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2004;4:327–37.A Comprehensive Evaluation of Left
Atrial Performance Using Volumetric
Analysis, Strain, and Strain Rate ImagingWe read with great interest the article by Habibi et al.
(1), which demonstrates the association of left atrial
(LA) function and the development of heart failure
using cardiac magnetic resonance (CMR) feature-
tracking. We fully agree that LA function
assessment has the potential to gain an incremental
role in the early diagnosis and risk stratiﬁcation
already at pre-clinical stages of heart failure (2).
As correctly cited by the investigators, LA
echocardiographic speckle tracking studies (3) have
demonstrated that a comprehensive assessment of LA
deformation should include strain and strain rate
parameters to describe the 3 functional components of
atrial physiology: 1) reservoir function (collection of
pulmonary venous return during ventricular systole—
assessed with global peak longitudinal strain and global
peak positive strain rate); 2) conduit function (passage of
blood to the left ventricle during early ventricular
diastole—assessed with global passive longitudinal strain
and global peak early negative strain rate); and 3)
contractile booster pump function (augmentation of
ventricular ﬁlling during late ventricular diastole—
assessed with global longitudinal strain during atrial
contraction and global peak late negative strain rate).
Furthermore, when using CMR, an atrial volumetric
analysis is also well established to assess these 3
functional components (4).
Habibi et al. (1) have now applied CMR feature-tracking
strain—but not strain rate—to assess LA reservoir and
contractile booster pump function without studying
conduit function. Conversely, they used volumetric
indices to study LA reservoir and conduit function but
not contractile booster pump function. It is important to
note that there is evidence to suggest that impaired LA
contractile booster pump function assessed with
volumetric analysis has strong prognostic implications
for adverse cardiac events (including development of
heart failure) in asymptomatic patients at risk for left
ventricular diastolic dysfunction (5).
A more comprehensive analysis including all atrial
deformation parameters (strain and strain rate) and
